Open AccessEosinophilic esophagitis during sublingual and oral allergen immunotherapy
Author(s) -
Joseph Cafone,
Peter Capucilli,
David R.C. Hill,
Jonathan M. Spergel
Publication year - 2019
Publication title -
current opinion in allergy and clinical immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.94
H-Index - 84
eISSN - 1528-4050
pISSN - 1473-6322
DOI - 10.1097/aci.0000000000000537
Subject(s) - eosinophilic esophagitis , medicine , immunotherapy , sublingual immunotherapy , desensitization (medicine) , allergen immunotherapy , oral immunotherapy , slit , incidence (geometry) , allergen , allergy , immunology , food allergy , dermatology , immune system , disease , physics , receptor , biology , optics , genetics
The aim of this review is to discuss the current evidence regarding the development of eosinophilic esophagitis (EoE) in individuals undergoing oral and sublingual immunotherapy (SLIT) for both food and environmental allergens. Cumulative incidence of EoE in patients on allergen immunotherapy for peanut, milk, and egg is estimated.